AKTX logo

Akari Therapeutics, Plc (AKTX)

Profile

Full Name

Akari Therapeutics, Plc

Ticker

NASDAQ: AKTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 6, 2014

Indexes

Not included

Website

http://www.akaritx.com

Employees

8

Key Details

Price

$1.10(-1.65%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

$0.00(0.00% YoY)

PE ratio

-

Next earnings date

Aug 19, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.10
    AKTX price is $1.10

    30-Day Relative Volume

    0.77
    AKTX 30-day relative volume is 0.77

    Price Performance

    Price Today change

    -1.65%
    AKTX price is down -1.65% today

    Price YTD change

    -9.71%
    AKTX price is down -9.71% since January 1st

    Price 1-year change

    -60.8%
    AKTX price is down -60.8% year-on-year

    Price 3-year change

    -94.38%
    AKTX price is down -94.38% over the past 3 years

    Price Range

    Price All-time high

    $2380.00
    AKTX price is currently -99.95% below its historical high of $2380.00

    Price 3-year low

    $0.85
    AKTX price is currently +29.59% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $35.44M
    AKTX market capitalization is $35.44 million

    Market cap 3-year change

    -39.06%
    AKTX market capitalization is down -39.06% over the past 3 years

    Market cap All-time high

    $282.57M
    AKTX market capitalization is currently -87.46% below its historical high of $282.57 million

    Market cap sector rank

    30.34%
    AKTX market capitalization is higher than 30.34% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +164.94%
    AKTX shares outstanding is up +164.94% year-on-year

    Shares Outstanding 3-Year Change

    +984.29%
    AKTX shares outstanding is up +984.29% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.51
    AKTX beta is 0.51

    200-day SMA

    $1.51
    AKTX price is currently -26.93% below its 200-day simple moving average

    50-day SMA

    $1.27
    AKTX price is currently -13.32% below its 50-day simple moving average

    RSI

    41.04
    AKTX 14-day relative strength index is 41.04

    Volume

    0.77
    AKTX 30-day relative volume is 0.77

    ATR

    $0.06
    AKTX average true range is $0.06

    10-day Historical Volatility

    29.53%
    AKTX 10-day historical volatility is 29.53%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    AKTX annual revenue value is unknown

    Revenue Analysts estimate

    -
    AKTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    AKTX annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    AKTX annual revenue is unknown

    EPS

    EPS

    $0.00
    AKTX annual earnings per share is $0.00

    EPS Analysts estimate

    -$0.45
    AKTX annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    AKTX {parameterFullLabel} has remained unchanged year-on-year

    EPS Sector rank

    81.44%
    AKTX annual earnings per share is higher than 81.44% of companies in Healthcare sector

    Profit

    Gross profit

    -
    AKTX annual gross profit value is unknown

    Gross margin

    -
    AKTX annual gross profit margin value is unknown

    Operating profit

    -$16.65M
    AKTX annual operating income is -$16.65 million

    Operating margin

    -
    AKTX annual operating profit margin value is unknown

    Net income

    -$19.79M
    AKTX annual net profit is -$19.79 million

    Net margin

    -
    AKTX annual net profit margin value is unknown

    Expenses

    Total expenses

    $16.65M
    AKTX annual total expenses is $16.65 million

    Operating expenses

    $16.65M
    AKTX annual total operating expenses is $16.65 million

    Cost of goods sold

    -
    AKTX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $9.66M
    AKTX annual SGA is $9.66 million

    Depreciation and amortization

    $14.00K
    AKTX annual depreciation & amortization is $14.00 thousand

    Interest expense

    $244.00K
    AKTX annual interest expense is $244.00 thousand

    Income tax

    -
    AKTX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$19.55M
    AKTX annual earnings before interest & taxes is -$19.55 million

    EBITDA

    -$19.53M
    AKTX annual EBITDA is -$19.53 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $50.56M
    AKTX annual total assets is $50.56 million

    Non current assets

    $47.61M
    AKTX annual long term assets is $47.61 million

    Current assets

    $2.95M
    AKTX annual total current assets is $2.95 million

    Cash and cash equivalents

    $2.60M
    AKTX annual cash & cash equivalents is $2.60 million

    Accounts receivable

    -
    AKTX annual accounts receivable value is unknown

    Inventory

    -
    AKTX annual inventory value is unknown

    Liabilities

    Total liabilities

    $28.33M
    AKTX annual total liabilities is $28.33 million

    Long term liabilities

    $8.42M
    AKTX annual total long term liabilities is $8.42 million

    Current liabilities

    $19.91M
    AKTX annual total current liabilities is $19.91 million

    Accounts payable

    $12.41M
    AKTX annual accounts payable is $12.41 million

    Debt

    Total debt

    $3.26M
    AKTX annual total debt is $3.26 million

    Total debt 1-year change

    +100%
    AKTX annual total debt is up +100% year-on-year

    Long term debt

    -
    AKTX annual long term debt value is unknown

    Short term debt

    $3.26M
    AKTX annual short term debt is $3.26 million

    Equity & Capital

    Shareholders equity

    $22.23M
    AKTX annual stockholders equity is $22.23 million

    Book value

    $22.23M
    AKTX annual book value is $22.23 million

    Retained earnings

    -$247.25M
    AKTX annual retained earnings is -$247.25 million

    Working capital

    -$16.96M
    AKTX annual working capital is -$16.96 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$12.55M
    AKTX annual cash flow from operations is -$12.55 million

    Cash from operations 1-year change

    +23.61%
    AKTX annual cash flow from operations is up +23.61% year-on-year

    Cash from investing

    $382.00K
    AKTX annual cash flow from investing activities is $382.00 thousand

    Cash from investing 1-year change

    +100%
    AKTX annual cash flow from investing activities is up +100% year-on-year

    Cash from financing

    $10.99M
    AKTX annual cash flow from financing activities is $10.99 million

    Cash from financing 1-year change

    +56.52%
    AKTX annual cash flow from financing activities is up +56.52% year-on-year

    CAPEX

    CAPEX

    -
    AKTX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    AKTX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$12.55M
    AKTX annual free cash flow is -$12.55 million

    Free cash flow 1-year change

    +23.61%
    AKTX annual free cash flow is up +23.61% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    AKTX annual gross profit margin value is unknown

    Operating margin

    -
    AKTX annual operating profit margin value is unknown

    Net margin

    -
    AKTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -39.14%
    AKTX annual return on assets is -39.14%

    ROE

    -89.03%
    AKTX annual return on equity is -89.03%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AKTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AKTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.63
    AKTX price to book ratio is 1.63

    PB ratio Sector rank

    50.5%
    AKTX price to book ratio is higher than 50.5% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    AKTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    AKTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $34.71M
    AKTX enterprise value is $34.71 million

    Enterprise value Sector rank

    33.25%
    AKTX enterprise value is higher than 33.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.97
    AKTX EV/EBITDA is -1.97

    EV/EBITDA Sector rank

    39.39%
    AKTX EV/EBITDA is higher than 39.39% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.15
    AKTX annual current ratio is 0.15

    Quick ratio

    -
    AKTX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.15
    AKTX annual debt to equity ratio is 0.15

    Interest coverage ratio

    -80.11
    AKTX annual interest coverage ratio is -80.11

    Risk & Stability

    Piotroski F-Score

    -
    AKTX piotroski f-score value is unknown

    Altman Z-Score

    -
    AKTX altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Dec 5, 22 HC Wainwright & Co.
    Buy
    Nov 1, 22 Alliance Global Partners
    Buy
    Mar 13, 20 B. Riley Securities
    Buy
    Mar 13, 20 B. Riley FBR
    Buy
    May 5, 18 B. Riley FBR
    Neutral
    Mar 29, 18 Canaccord Genuity
    Buy
    Feb 8, 18 B. Riley Securities
    Neutral
    Feb 8, 18 B. Riley FBR
    Neutral
    Sep 22, 17 William Blair
    Outperform
    May 31, 17 Chardan Capital
    Neutral

    Institutional Ownership

    Screeners with AKTX included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Akari Therapeutics, Plc?
    • Does Akari Therapeutics, Plc pay dividends?
    • What sector is Akari Therapeutics, Plc in?
    • What industry is Akari Therapeutics, Plc in?
    • What country is Akari Therapeutics, Plc based in?
    • When did Akari Therapeutics, Plc go public?
    • Is Akari Therapeutics, Plc in the S&P 500?
    • Is Akari Therapeutics, Plc in the NASDAQ 100?
    • Is Akari Therapeutics, Plc in the Dow Jones?
    • When was Akari Therapeutics, Plc's last earnings report?
    • When does Akari Therapeutics, Plc report earnings?

    What is the ticker symbol for Akari Therapeutics, Plc?

    The ticker symbol for Akari Therapeutics, Plc is NASDAQ:AKTX

    Does Akari Therapeutics, Plc pay dividends?

    No, Akari Therapeutics, Plc does not pay dividends

    What sector is Akari Therapeutics, Plc in?

    Akari Therapeutics, Plc is in the Healthcare sector

    What industry is Akari Therapeutics, Plc in?

    Akari Therapeutics, Plc is in the Biotechnology industry

    What country is Akari Therapeutics, Plc based in?

    Akari Therapeutics, Plc is headquartered in United States

    When did Akari Therapeutics, Plc go public?

    Akari Therapeutics, Plc's initial public offering (IPO) was on January 6, 2014

    Is Akari Therapeutics, Plc in the S&P 500?

    No, Akari Therapeutics, Plc is not included in the S&P 500 index

    Is Akari Therapeutics, Plc in the NASDAQ 100?

    No, Akari Therapeutics, Plc is not included in the NASDAQ 100 index

    Is Akari Therapeutics, Plc in the Dow Jones?

    No, Akari Therapeutics, Plc is not included in the Dow Jones index

    When was Akari Therapeutics, Plc's last earnings report?

    Akari Therapeutics, Plc's most recent earnings report was on May 15, 2025

    When does Akari Therapeutics, Plc report earnings?

    The next expected earnings date for Akari Therapeutics, Plc is August 19, 2025
    On this page